Kirsten Hattermann - Search Results

Year	Number of Results
2007	1
2008	3
2009	1
2010	3
2011	6
2012	7
2013	5
2014	3
2015	4
2016	8
2017	3
2018	4
2019	1
2020	5
2023	4
2024	2

1

Resveratrol Mitigates Metabolism in Human Microglia Cells.

Schlotterose L, Pravdivtseva MS, Ellermann F, Jansen O, Hövener JB, Sönnichsen FD, Cossais F, Lucius R, Hattermann K. Schlotterose L, et al. Among authors: hattermann k. Antioxidants (Basel). 2023 Jun 9;12(6):1248. doi: 10.3390/antiox12061248. Antioxidants (Basel). 2023. PMID: 37371977 Free PMC article.

2

Lost in disruption: role of proteases in glioma invasion and progression.

Mentlein R, Hattermann K, Held-Feindt J. Mentlein R, et al. Among authors: hattermann k. Biochim Biophys Acta. 2012 Apr;1825(2):178-85. doi: 10.1016/j.bbcan.2011.12.001. Epub 2011 Dec 22. Biochim Biophys Acta. 2012. PMID: 22209868 Review.

3

An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology.

Hattermann K, Mentlein R. Hattermann K, et al. Ann Anat. 2013 Mar;195(2):103-10. doi: 10.1016/j.aanat.2012.10.013. Epub 2012 Dec 8. Ann Anat. 2013. PMID: 23279723 Review.

4

Modeling treatment-dependent glioma growth including a dormant tumor cell subpopulation.

Böttcher MA, Held-Feindt J, Synowitz M, Lucius R, Traulsen A, Hattermann K. Böttcher MA, et al. Among authors: hattermann k. BMC Cancer. 2018 Apr 3;18(1):376. doi: 10.1186/s12885-018-4281-1. BMC Cancer. 2018. PMID: 29614985 Free PMC article.

5

The CXCL16-CXCR6 chemokine axis in glial tumors.

Hattermann K, Held-Feindt J, Ludwig A, Mentlein R. Hattermann K, et al. J Neuroimmunol. 2013 Jul 15;260(1-2):47-54. doi: 10.1016/j.jneuroim.2013.04.006. Epub 2013 Apr 28. J Neuroimmunol. 2013. PMID: 23628207

6

Erythropoietin and CCL3 antagonise their functional properties during neuroinflammation.

Hattermann K, Knerlich-Lukoschus F, Lucius R, Mehdorn M, Held-Feindt J. Hattermann K, et al. Neurol Res. 2015 Nov;37(11):1025-8. doi: 10.1179/1743132815Y.0000000070. Epub 2015 Jul 16. Neurol Res. 2015. PMID: 26178913

7

SP100 reduces malignancy of human glioma cells.

Held-Feindt J, Hattermann K, Knerlich-Lukoschus F, Mehdorn HM, Mentlein R. Held-Feindt J, et al. Among authors: hattermann k. Int J Oncol. 2011 Apr;38(4):1023-30. doi: 10.3892/ijo.2011.927. Epub 2011 Jan 27. Int J Oncol. 2011. PMID: 21274506

8

Macroscopic Silicone Microchannel Matrix for Tailored Drug Release and Localized Glioblastoma Therapy.

Rasch F, Schmitt C, Saure LM, Meyer R, Adamski V, Dengiz D, Scherließ R, Lucius R, Synowitz M, Mishra YK, Hattermann K, Adelung R, Held-Feindt J, Schütt F. Rasch F, et al. Among authors: hattermann k. ACS Biomater Sci Eng. 2020 Jun 8;6(6):3388-3397. doi: 10.1021/acsbiomaterials.0c00094. Epub 2020 Apr 22. ACS Biomater Sci Eng. 2020. PMID: 33463157

9

Stem cell markers in glioma progression and recurrence.

Hattermann K, Flüh C, Engel D, Mehdorn HM, Synowitz M, Mentlein R, Held-Feindt J. Hattermann K, et al. Int J Oncol. 2016 Nov;49(5):1899-1910. doi: 10.3892/ijo.2016.3682. Epub 2016 Sep 6. Int J Oncol. 2016. PMID: 27600094

10

Breaking the circulus vitiosus of neuroinflammation: Resveratrol attenuates the human glial cell response to cytokines.

Schlotterose L, Cossais F, Lucius R, Hattermann K. Schlotterose L, et al. Among authors: hattermann k. Biomed Pharmacother. 2023 Jul;163:114814. doi: 10.1016/j.biopha.2023.114814. Epub 2023 May 4. Biomed Pharmacother. 2023. PMID: 37148859 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

52 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year